Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates UTHR Bullish with a Setup Score of 0, net conviction 56, actionability 0. How the Setup Score works →
Total Setup Score
0
Directional Bias
Bullish
Net Conviction
56
Actionability
0 (in range)
Key signals behind this score
40wk Uptrend — rising+above (sma 510 vs px 547)
Fresh Trend Turn — 40wk turn 41w · aligned 43w
80wk Uptrend — rising+above (sma 419 vs px 547)
200wk Uptrend — rising+above (sma 326 vs px 547)
Funds Accumulating — momZ +1.67 · 9.43→9.70
Short Squeeze Setup — velZ +1.11 · age 103w×0.45 · 5.27%
Founder-Led — founder/CEO led
About United Therapeutics Corporation
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arteria… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NASDAQ
IPO Date: June 17, 1999
Headquarters: 1000 Spring Street, Silver Spring, MD, United States, 20910
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$553.68
Near-term / short-term trend
Weekly
40-Week SMA
$510.04
Medium-term trend
Weekly
80-Week SMA
$419.12
Cyclical trend (business cycle)
Weekly
200-Week SMA
$325.74
Secular trend (multi-year)
Monthly
10-Month SMA
$520.21
Near-term monthly trend
Monthly
20-Month SMA
$422.12
Medium-term monthly trend
Monthly
40-Month SMA
$343.91
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for United Therapeutics Corporation
(UTHR) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.